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Background: Disease of the aortic valve in children and young adults is a complex
entity whose management is the subject of controversy. The Ross and the Ross-
Konno procedures have become the primary choices for aortic valve replacement in
children because of growth potential, optimal hemodynamic performance, and lack
of the need for anticoagulation. However, concern persists regarding the longevity
of the pulmonary autograft, especially in patients with aortic insufficiency.
Methods: Between June 1993 and February 2000, 72 Ross and Ross-Konno proce-
dures were performed at our institution: 81% of the patients were less than 15 years
old. Preoperative, postoperative, and follow-up clinical, echocardiographic, and
hemodynamic data were reviewed. Statistical analysis was performed to identify the
risk factors for deteriorating autograft function.
Results: Aortic insufficiency was an indication for the Ross procedure in 17 patients
and mixed lesions with predominant aortic insufficiency in 10. Of the 45 other
patients, 32 had aortic stenosis and 13 had mixed lesions with predominant aortic
stenosis. There were no deaths during a follow-up of 5 to 80 months. Autograft reop-
eration was necessary in the follow-up period in 7 patients for severe aortic insuffi-
ciency. Moderate insufficiency was identified in 5 additional patients. Aortic insuffi-
ciency or predominant aortic insufficiency, as a preoperative hemodynamic indication
for the Ross procedure, reached statistical significance (P = .031) as a risk factor for
autograft failure.
Conclusion: The Ross and the Ross-Konno procedures have changed the prognosis
of children and young adults with complex aortic valve disease. However, the Ross
procedure should be performed with caution in older children in whom aortic insuf-
ficiency is a preoperative hemodynamic indication. Further follow-up to delineate
the risk factors for autograft dysfunction in children and young adults is necessary
to better define the indications for the Ross procedure. 
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Aortic valve disease in children and youngadults is often a difficult and complexproblem whose management strategiesare the subject of controversy.1 In the past,traditional options included open surgicalvalvotomy or transcatheter balloon valvu-
loplasty. Treating significant residual lesions with conserva-
tive measures was considered reasonable because the only
acceptable alternative would have been a prosthetic valve
replacement.
The Ross and the Ross-Konno procedures have become
an important option for aortic valve replacement (AVR) in
patients with both congenital and acquired disease of the left
ventricular outflow tract (LVOT).2-6 The acceptance of these
procedures has been slow because of the technical demands
of the operations and the inherent need for reconstruction of
the right ventricular outflow tract, thereby placing two
valves at risk. Although more than 3 decades have passed
since the Ross procedure was first described, in the past 10
years it has been increasingly considered for pediatric
patients with a wide spectrum of congenital abnormalities of
the LVOT.4-7
The advantages of the autograft valve include growth
potential, optimal hemodynamic performance, freedom
from anticoagulation, and hemolysis.7-11 However, concerns
regarding the Ross procedure persist: potential dilatation of
the autograft, reoperation for autograft dysfunction, and
replacement of right ventricular outflow tract conduits.
Further, doubts have been expressed by others regarding the
indications for the Ross procedure in patients with a bicus-
pid aortic valve and with aortic valve insufficiency (AI).12,13
We reviewed our experience to identify the risk factors for
the failure of the pulmonary autograft and to determine
whether the primary diagnosis (congenital aortic stenosis
[AS] or AI) or preoperative indications (AS, AI, or mixed
lesion) are risk factors for pulmonary autograft failure.
Methods
A retrospective review of all patients who underwent the Ross or
Ross-Konno operation between June 1993 and February 2000 was
performed. All patients had preoperative transthoracic echocardio-
graphic evaluation, with the findings being confirmed by intraoper-
ative transesophageal echocardiography. All patients were followed
up clinically and with multiple transthoracic echocardiographic
examinations.
We defined failure of the Ross procedure as (1) echocardio-
graphic presence of at least moderate AI or (2) surgical interven-
tion for pulmonary autograft dysfunction. Risk factors considered
for autograft failure were as follows: preoperative hemodynamic
indications (AI vs AS), sex, aortic valve anulus, pulmonary
valve–aortic valve anulus mismatch, aortic crossclamp time, total
bypass time, previous surgery on the LVOT, Ross-Konno proce-
dure, attempted aortic valve repair, external noncoronary sinus
support, and additional surgical procedures. In addition, the size of
the aortic anulus at the time of autograft implantation and its rela-
tion to the expected normal for the patient’s body surface area were
analyzed. The aortic valve anulus was categorized as stenotic if it
was smaller than 2 standard deviations below the expected size for
the patient’s body surface area and as dilated if larger than 2 stan-
dard deviations above the expected size.14 There were too few fail-
ures for analysis of the primary diagnosis (4 categories) and aortic
valve morphology (5 categories).
Statistics
Descriptive statistics are expressed as median and range. Actuarial
freedom from reintervention was determined by the Kaplan-Meier
method. The Cox proportional hazards models (univariate and
multivariate) evaluated potential predictors of time of autograft
failure. Their effects are summarized by estimated hazard ratios,
which are equal to 1.0 if there is no impact on risk of failure,
greater than 1.0 if there is an increased risk of failure, and less than
1.0 if there is a reduced risk of failure. Statistical analysis was per-
formed with SAS system software version 8.0 (SAS Institute, Inc,
Cary, NC).
Demographics
Between June 1993 and February 2000, a total of 72 patients
underwent a Ross or Ross-Konno procedure (excluding the
patients with borderline hypoplastic left heart syndrome). There
were 53 male (74.6%) and 19 female (26.4%) patients. Median age
was 9.1 years, with a range between 4 days and 39.6 years (81%
less than 15 years old) (Figure 1). Congenital AS was the primary
diagnosis in 60 patients and congenital AI in 9. Two patients had
rheumatic aortic valve disease and 1 had aortic valve endocarditis.
Morphologic characteristics of the aortic valve are shown in Figure
2. A bicuspid aortic valve was present in 52 patients. The preoper-
ative hemodynamic indication was AS in 32 patients, AI in 17
patients, and mixed lesion with predominant AS in 13 patients and
predominant AI in 10 patients (Figure 3).
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Figure 1. Age distribution of patients.
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Operative Technique
Standard techniques of neonatal and pediatric cardiopulmonary
bypass were used, with bicaval cannulation, moderate hypothermia,
and antegrade cold crystalloid cardioplegia. A standard freestanding
root technique was used for the Ross procedure (18 patients) and the
Ross-Konno procedure (16 patients), as previously described.9,11
When a Ross-Konno procedure was being performed, the autograft
was harvested with an extension of attached infundibular free wall
muscle for use in patching the ventriculoplasty incision. The external
noncoronary sinus support technique with native aortic tissue was
applied in 38 of the 72 patients (sinus obliteration technique10). The
patients were separated from bypass in the usual manner and trans-
esophageal echocardiography was performed.
Results
There were no deaths. The follow-up ranged from 5 to 80
months. Seven patients underwent reoperation for pul-
monary autograft dysfunction: Six patients received a
mechanical aortic valve, and in 1 patient the autograft valve
could be satisfactorily repaired. Actuarial freedom from
autograft reintervention was 82% ± 6.2% (standard error) at
80 months (Figure 4).
Five patients who had echocardiographic evidence of mod-
erate AI are still being followed up without surgical inter-
vention. Our review of the 12 patients with pulmonary auto-
graft failure showed no evidence of AI at the intraoperative
transesophageal echocardiogram, at the discharge transtho-
racic echocardiogram, and at the 1-year follow-up period. A
review of all the operative reports reveals no concern about
technical issues. All 12 patients with autograft failure were
less than 15 years old (10 of 12 were less than 10 years old).
Preoperative hemodynamic indications for the Ross proce-
dure in the 7 patients reoperated on for autograft dysfunction
were severe AI in 3 patients, severe AS in 2 patients, and
mixed lesions in 2 patients (1 predominant AI, 1 predominant
AS). The primary diagnoses in these 7 patients were congeni-
tal AS in 6 patients and rheumatic disease in 1 patient.
Our thresholds for autograft reintervention were dictated
by early echocardiographic findings of left ventricular
enlargement and severity of AI. All 7 patients undergoing
reoperation had severe AI, but 5 of them were completely
asymptomatic (New York Heart Association class I).
The echocardiographic findings in the 7 patients under-
going reoperation were uniformly significant for severe
AI, dilatation of the aortic anulus, dilatation of the sinus-
es of Valsalva, dilatation of the sinotubular junction, and
lack of central leaflet coaptation with central jet regurgi-
tation.
In the 7 patients who underwent reoperation for auto-
graft failure, 6 patients required AVR with a mechanical
prosthesis. In 1 patient, the valve was able to be repaired.
Among the 6 patients who had AVR, the operative find-
ings were uniformly consistent with dilatation of the aor-
tic anulus, dilatation of the sinotubular junction, and lack
of central leaflet coaptation. The leaflets were described
Figure 2. Aortic valve morphology.
Figure 3. Preoperative hemodynamic indications.
Figure 4. Actuarial freedom from autograft reintervention.  FU,
Follow-up.
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uniformly as “thin.” The patient who underwent repair
had prolapse of 1 leaflet that was partially resected and
resuspended. Light microscopy showed a spectrum of
histopathologic abnormalities. In a specimen that had
been in place for 2 years, there was fibrosis at the free
margin of the valve. Within this fibrosis was a myxoid
extracellular matrix, a nonspecific change consistent with
hemodynamic abnormality. Specimens that had been in
place for 4 to 5 years had more dense fibrosis and less
myxoid matrix. Preoperative hemodynamic indications
for the Ross procedure in the 5 patients currently having
echocardiographic evidence of moderate AI were severe
AI in 2 patients and mixed lesions with predominant AI in
3 patients. The primary diagnoses were congenital AS in
4 patients and congenital AI in 1 patient.
Table 1 shows the estimated effects of predictors from
univariate Cox proportional hazards models of time to any
failure (reintervention or AI). Only preoperative hemody-
namic indication of AI reached statistical significance, and
all estimates have wide confidence intervals (CI), reflecting
the presence of only 12 failures in the data set. In a 2-pre-
dictor model with hemodynamic indication of AI and aortic
valve anulus size, both predictors reached statistical signifi-
cance (AI: hazard ratio 5.7, 95% CI 1.4-22.3, P = .013; aor-
tic valve anulus size: hazard ratio 0.90 per millimeter, 95%
CI 0.83-0.98, P = .016). No other predictors reached statis-
tical significance when added to models already containing
hemodynamic indications.
Discussion
The Ross procedure (pulmonary autograft replacement of
the aortic valve) is applicable to patients with both con-
genital and acquired disease of the LVOT.15-20 Despite its
slow initial acceptance, the procedure recently has been
increasingly used for pediatric patients with a wide spec-
trum of congenital abnormalities of the LVOT.21-24 The
prognosis of infants, children, and young adults with
severe and complex aortic valve disease has been substan-
tially altered with the use of the pulmonary autograft tech-
nique. Complex and multilevel LVOT obstruction requir-
ing aortoventriculoplasty, bicuspid or tricuspid aortic
valve disease associated with AI, dilatation of the aortic
anulus, and bacterial endocarditis are pathologic entities
for which a pulmonary autograft is used in conjunction
with modifications of the Ross procedure.12,13,25 The char-
acteristics of the ideal valve, which comprise minimal
transvalvular gradient, growth potential, no thrombo-
embolism, and no anticoagulation-related hemorrhage, are
satisfied. The broadening indications and the growing
enthusiasm for the Ross procedure should be carefully
weighed against the increasing concern regarding the dura-
bility of the autograft valve, the potential dilatation of the
autograft, the incidence of reoperations, and the residual or
increasing autograft insufficiency.
Possible factors responsible for autograft failure include
technical imprecision, the type of replacement (freestanding
root, root inclusion, and subcoronary implant), status of the
Surgery for Congenital Heart Disease Laudito et al
TABLE 1. Predictors of autograft failure in univariate Cox proportional hazards models
Predictor Hazard ratio 95% CI P value
Male 1.39 0.30-6.4 .67
Age (per year) 0.95 0.87-1.04 .30
Prior LVOT surgery 0.83 0.27-2.6 .75
Ross (vs Ross-Konno) 0.74 0.22-2.5 .62
Attempted repair 0.47 0.06-3.7 .47
Sinus obliteration technique 2.6 0.72-9.1 .15
Hemodynamic diagnosis of AI (vs AS)* 4.2 1.14-15.7 .031
AV anulus (per mm) 0.93 0.85-1.01 .099
Stenotic (vs normal)† 0.91 0.11-7.8 .93
Dilated (vs normal)† 0.42 0.10-1.8 .24
PV-AV (per mm) 1.07 0.92-1.23 .37
Crossclamp time (per hour) 0.90 0.39-2.1 .81
Total CPB time (per hour) 0.68 0.36-1.27 .23
Additional procedure 0.79 0.24-2.6 .70
Absolute PV anulus 1.01 0.80-1.27 .96
Absolute PV-AV anulus 1.7 0.33-9.3 .52
CI, Confidence interval; LVOT, left ventricular outflow tract; AI, aortic insufficiency; AS, aortic stenosis; AV, aortic valve; CPB, cardiopulmonary bypass; 
PV, pulmonary valve.
*AI only or predominant in mixed lesion. 
†Defined as AV anulus > 2 standard deviations below (stenotic) or above (dilated) the expected value for the patient’s body surface area.
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LVOT and ascending aorta, and inherent disease of the pul-
monary valve.
All patients in our series underwent a Ross procedure as
root replacement. Thirty-eight patients received the modifi-
cation that we have called the sinus obliteration technique.
Sixteen patients underwent the Ross-Konno procedure.
Neither of these variables was identified as a statistically
significant risk factor for autograft failure. All 12 patients
with autograft failure were less than 15 years old, with 10 of
them less than 10 years old. None of the 7 patients requiring
reoperation were treated with the sinus obliteration tech-
nique. The pathologic findings suggested a progression of
repair from myxoid extracellular matrix (indicative of tur-
bulence) to dense fibrosis in the old specimens. The
histopathologic characteristics were not helpful in ascertain-
ing the precise cause of failure of the Ross procedure. A pre-
operative hemodynamic indication of AI, either isolated or
as part of a mixed lesion, appeared to be a risk factor for
development of autograft failure.
Elements that make AI a risk factor are speculative. One
issue immediately considered is dilatation of the anulus.
Larger aortic valve anulus appeared to be associated with
reduced risk. This was particularly true in a model that also
controlled for hemodynamic indications, but the small num-
ber of events makes this multivariate analysis tenuous. Size in
relation to that expected for body surface area, however, did
not appear to be predictive, nor did geometric mismatch (this
was true for both the absolute magnitude of the mismatch and
the magnitude as a percentage of the aortic valve anulus).14,15
It is possible, therefore, that other unknown factors influence
this event. Perhaps chronic AI alters the geometry and tissue
characteristics of the subvalvular LVOT, leading to failure of
the Ross procedure. Another possibility is that these patients
may have a subtle inherent abnormality of the pulmonary
anulus or valve that becomes significant when the valve is
placed in the systemic circulation.13,26,27 It has also been
shown28 that postoperative control of blood pressure may be
critically important in avoiding structural and mechanical
adaptation phenomena in the wall of the autograft (elastic
fiber fragmentation), which can further progress to root
dilatation. The potential of reducing the incidence of late
autograft valve insufficiency is certainly available.20-22,24 We
did not consider plicating the anulus because of the growth
issue in the young patient population that we treated,
although we agree that annular reinforcement should be a
consideration in patients in whom adequate size has been
achieved (over 15 years old). However, at present we recom-
mend a bileaflet mechanical prosthesis, rather than the Ross
procedure, as a first choice in this patient population.
It should be emphasized that AI, as a preoperative hemody-
namic indication for surgery, is not an absolute contraindica-
tion to the Ross procedure, but a relative risk factor that needs
to be considered in the complex process of identifying the
best option for an individual patient. Further multicenter stud-
ies to identify the risk factors for autograft dysfunction in
children and young adults will be necessary to better define
the selective indications for the Ross procedure.
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Discussion
Dr Ronald C. Elkins (Oklahoma City, Okla). Dr Laudito and the
group from San Francisco are to be congratulated for bringing their
concerns to all surgeons interested in the Ross operation. 
The frequency of autograft reintervention in their 72 patients,
based on the development of autograft insufficiency and left ven-
tricular enlargement, is higher than one would anticipate on the
basis of a review of current reported studies. This present report is
unique in its high incidence of autograft failure, the particularly
early occurrence of autograft failure, and also in the surgical tech-
nique used for the operation. 
In an effort to maintain normal anatomic relationships, most sur-
geons performing the Ross operation implant the pulmonary root
and its contained valve as a freestanding root with the coronaries
implanted as buttons and do not support the pulmonary sinus or
alter the sinotubular junction at the time of implantation. 
During the 10-plus years in which a significant number of root
replacements have been performed, several factors that affect pul-
monary autograft valve function have been identified. Probably the
most important of these is that the autograft pulmonary root does
not remodel to become an aortic root and one should not force it to
be one. 
When compared with the normal aortic route, the pulmonary
root immediately dilates when placed in the systemic circulation.
Several studies have now identified that this dilatation involves the
anulus, the sinus, and to a lesser extent the sinotubular junction.
The increase is about 9% in the first postoperative week and anoth-
er 10% in the first year. From that point on, in most patients this
dilatation remains very stable. 
If one reviews our own study, we have 208 patients who fit in an
age group similar to that which Dr Laudito described, and 123 of
these patients are less than 16 years of age. The total follow-up on
this patient group is 754 patient-years with 61 patients having been
followed up for 5 years or more. 
The actual freedom from reoperation for autograft valve insuffi-
ciency in this group is 91%. The actual freedom from valve replace-
ment is 96%. When we analyze this group of patients on the basis of
their primary valve lesion or their predominant hemodynamic lesion,
we can find no indication that either of these factors affects the inci-
dence of autograft valve insufficiency or reintervention. 
As I reviewed the manuscript, several factors concerned me.
First, there is no discussion of the operative findings associated
with autograft valve insufficiency. Why did these valves leak? Can
you provide some information? There is no discussion of the sur-
gical pathology of the explanted autograft valves. 
You identified in your analysis that there was no difference
between the Ross and Ross-Konno operations in terms of outcome.
However, you did not discuss any of the impact that your sinus
obliteration technique might have on late outcome. Is it possible
that the subtle alterations in the sinotubular junction during your
coronary implantation for prevention of the normal, early dilata-
tion of the noncoronary sinus produced an unfavorable effect on
your results? 
We have previously identified the importance of preoperative
aortic annular dilatation and its impact on late results. Except in
young children with significant growth potential, we have adopted
a policy of annular reduction and fixation of the aortic anulus with
a maximum follow-up of 4 years in this group of patients. It
appears that this practice has reduced our incidence of moderate
autograft insufficiency and early autograft failure. How have you
managed the patients in your series with AI who have significant
aortic anulus dilatation? 
Dr Laudito. Thank you, Dr Elkins, for your kind comments.
Most of what I have learned about the Ross procedure was
obtained through your published data. 
It is true that we did not discuss the pathologic findings of the
valve in our manuscript. We had 7 patients; 6 underwent mechan-
ical AVR and 1 underwent aortic valvuloplasty. In the majority of
these patients, the pathologic finding was thinning of the leaflet
with almost uniform dilatation of the root. That essentially is the
remarkable point. 
Regarding the sinus obliteration technique, both we and the sta-
tistician at our university performed both univariate and multivari-
ate analyses, and we found no statistical difference. We believe
from a surgical point of view that it is not a positive or negative
point at present. 
Regarding annular dilatation, as you mentioned earlier, even your
1994 article described pathologic evidence. The anulus dilates in the
first year and then there is the potential for growth. Because we are
treating patients who are very young, except for those rare adult
patients in our statistics, we are very concerned about the potential
growth of these patients. That is why we are not performing annular
reduction. 
Regarding your question of how to handle a dilated anulus, I have
to make a separation between 2 case scenarios. In 15-, 16-, or 17-
year-old patients, weighing about 50 kg, we will present the 2
options of the Ross procedure to the parents of the patient, along
with our assessment of the risk factors. However, in a patient of that
age and body size, we recommend AVR with a mechanical valve. If
the situation instead involves a younger patient, 3 or 4 years old, we
will perform the Ross operation without any annular reduction. 
Dr Zohair Al-Halees (Riyadh, Saudi Arabia). Although our
population of patients is different from yours, I think some infer-
ences can be made from examining our patients. Among 250
patients who underwent the Ross procedure at our hospital, about
70% have rheumatic etiology of their aortic valve disease, with an
incidence of reoperation in the range of 16%. However, when we
evaluate the reoperations more closely, we find that all of them,
Surgery for Congenital Heart Disease Laudito et al
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except for one, occurred in patients who initially had AI. Actually,
in the 1 patient with AS who required reoperation, the reason for
the reoperation was endocarditis. 
From this, we conclude that patients who start with pure AS or who
have a mixed lesion (AI and AS) with AS being the predominant
lesion do very well with the Ross procedure, with a very low inci-
dence of reoperation for up to 9 years of follow-up. Therefore, one
can safely say that the Ross procedure is the treatment of choice for
young patients with AS or mixed lesions with AS as the major lesion.
However, patients who initially have AI are the high-risk group, par-
ticularly if they have a dilated aortic root. In our patients who fit this
category, we modify the techniques and selection somewhat. We
started to exclude patients with dilated aortic roots of more than 28
mm. We believe these are not good candidates for the Ross proce-
dure. Borderline size aortic roots we reinforce with Teflon or a peri-
cardial strip. Unlike what Dr Elkins has mentioned, we have not
adopted the root reduction techniques because I believe that dilated
roots will continue to dilate. Some roots will even dilate after rein-
forcement with Teflon or pericardium. We also found that concomi-
tant severe mitral valve regurgitation requiring surgical intervention
is a strong predictor of Ross procedure failure.
With this information, have you changed anything in your
approach to patients who have AI? 
Dr Laudito. Thank you for the question and thank you for giv-
ing me the opportunity to further stress two concepts. We have a
high incidence of autograft failure because we are very aggressive
with the echocardiographic follow-up of the patients concerning
the protection of left ventricular function. If there is any evidence
of enlargement of the left ventricle, we immediately recommend
surgical intervention.
Regarding the issue of reinforcing the anulus of patients present-
ing with AI, we are limited by the element of growth in our young
patient population. When the patient reaches adult size around 15
years of age, we recommend a bileaflet mechanical prosthesis.
Tatoulis (J Heart Valve Dis 1996;5:491-7) reported a follow-up
of 14 years on aortic valve replacement with a mechanical pros-
thesis where the incidence of reoperation is lower than that of the
pulmonary autograft, but there is also a presence of morbidity,
related to the anticoagulant therapy, absent in the series with the
Ross procedure.
Dr Gerhard Ziemer (Tuebingen, Germany). I have an 11-year
experience with the Ross procedure, but I have restricted myself
mainly to patients less than 5 years of age. My first neonate to
receive a Ross procedure has 11 years of very satisfactory follow-
up. Most recently, with the advent of the Internet, the patients and
parents are almost demanding the Ross operation, so at some point
you have to do it. The result is that within the past 12 months, I
have my first 2 failures. These are 2 patients, 11 and 24 years old,
who within 3 months postoperatively had grade 4 AI. Both had ini-
tially left the hospital without AI. In the 11 year old, we did sinus
plasty as a secondary operation. Although the patient left the hos-
pital again with no AI, 3 months later grade 3 AI was detected. The
24 year old had received anulus reinforcement with Dacron pri-
marily, but grade 4 AI developed. At reoperation, he had nice coap-
tation of the leaflets but frank rupture in 2 of 3 leaflets.
Pathohistologic examination showed myxomatous degeneration. 
I have 2 questions: First, have you seen any pathologic condi-
tions like that? Second, what did you really change in your prac-
tice through the Ross experience and how do you use your word of
caution in your own practice?
Dr Laudito. Thank you for the questions. What we were con-
cerned with in the beginning of the study was the importance of the
primary diagnosis in autograft failure. What we learned is that part
of the patients who start with congenital AS and end up having sur-
gical balloon valvotomy, valvuloplasties are losing the diagnostic
identity of AS and are acquiring the hemodynamic diagnosis of AI.
This event will be significant for the future failure of the pul-
monary autograft.
Answering the second question, in the beginning, we were very
supportive of the Ross procedure. We are still performing the pro-
cedure in neonates, infants, and children, but we are changing our
manner of treating patients who are more than 15 years old with an
adult body size. We recommend in this patient population a
bileaflet mechanical prosthesis.
Dr William G. Williams (Toronto, Ontario, Canada). I would
like to ask Dr Elkins to comment on the role of reoperation for
repair of an autograft that is failing. What is the timing of that in
your series? 
Dr Elkins. I would reoperate on a patient who has central auto-
graft insufficiency in which there is echocardiographic evidence
that the autograft anulus has dilated since the initial operation and
that central AI is progressing. That patient would be treated by
anulus reduction. If the sinotubular junction was dilated, that
would also be restored to normal. 
Early in our experience with the Ross operation a number of
patients required repair, but since introducing our techniques of
fixation of the autograft anulus, we have had fewer reoperations. If
a patient weighs 50 kg and has a 23-mm aortic anulus, the valve
will fail unless something is done. That is an abnormal anulus size
for that patient. I do not wait for symptoms to appear. I operate rel-
atively early. In over 70% of the patients, we have been able to
restore the autograft valve function to normal. Our longest follow-
up period in a patient with an autograft repair is 7 years and he is
still doing well. 
